Stroke is the top cause of disability worldwide—and the second leading cause of death—but early intervention can prevent severe consequences, and a new tool could be a game-changer. Researchers at Massachusetts’ Brigham and Women’s Hospital developed a new test by combining blood-based biomarkers with a clinical score to identify patients experiencing large vessel occlusion strokes (LVO) with high accuracy.
The Teal Wand is an at-home self-collect device that aims to improve rates of screenings and provide a comfortable and accessible alternative to traditional pap smears. The U.S. Food and Drug Administration has now granted the Teal Wand with Breakthrough Device status; a designation awarded to medical devices that the FDA considers “life-saving” or “life-changing.”
Synthetic opioids are one of the main drivers in overdose deaths in the United States. They are often mixed with other drugs, but because of their potency, they are often present in such small amounts that they can be hard to detect. The new sensor, developed by researchers at the University of Pittsburgh, uses carbon nanotubes and gold nanoparticles to tell the most deadly drugs apart from others.
In a historic win for the LGBTQ+ community, Aetna reached a settlement today with a group of plaintiffs alleging medical discrimination in their fertility coverage. The insurance company is paying out $2 million to the members of the class action lawsuit, as well as restructuring how they cover fertility for queer couples moving forward. This marks the first big step toward ending fertility-based medical discrimination for LGBTQ+ couples.
Denmark is easing its abortion law for the first time in 50 years to allow women to terminate their pregnancies up to the 18th week. The new rules will also allow 15 to 17-year-olds to have an abortion without parental consent and will replace the five regional abortion consultations with a new national abortion board, to avoid local differences.
In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine developed at the University of Florida quickly reprogrammed the immune system to attack glioblastoma, the most aggressive and lethal brain tumor.
In a first-ever human clinical trial of adult patients, an mRNA cancer vaccine developed at the University of Florida reprogrammed the immune system to attack glioblastoma, the most aggressive and lethal brain tumor. The results mirror those in 10 pet dog patients suffering from brain tumors, as well as results from preclinical mouse models. The breakthrough will now be tested in a Phase 1 pediatric clinical trial.
There’s a global shortage of blood supplies needed for life-saving transfusions due to factors that include an aging population with a higher demand for it and a lack of volunteer donors. To help address this challenge, researchers at the Technical University of Denmark (DTU) and Lund University, Sweden, have used enzymes produced by a common gut bacteria to remove the A and B antigens from red blood cells, bringing them one step closer to creating universal donor blood.
Nets treated with two types of insecticide rather than one were trialed in 17 African countries where malaria is endemic between 2019 and 2022. During clinical trials when a net was coated with the insecticides pyriproxyfen or chlorfenapyr, alongside pyrethroid, malaria transmissions were reduced by between 20% and 50%. More than 600,000 people died from malaria in 2022 and 249 million people were infected, according to the latest data from the World Health Organization.
Nigeria has become the first country to roll out a “revolutionary” five-in-one vaccine against meningitis, the World Health Organization has announced. The Men5CV vaccine offers a powerful shield against the five major strains of the meningococcal bacteria that cause the disease. Known by the brand name MenFive, it provides broader protection than the vaccine currently used in much of Africa.
According to a recent study from Our World In Data, in the early-to-mid 20th century, the average annual death toll from disasters was very high, often climbing to over a million. In recent decades, such deaths are typically fewer than 20,000 people, even as natural disasters become more frequent and more extreme.
